Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Published:2010-05-26 Issue:3 Volume:55 Page:421-429
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Gorman Matthew F.,Ji Lingyun,Ko Richard H.,Barnette Phillip,Bostrom Bruce,Hutchinson Raymond,Raetz Elizabeth,Seibel Nita L.,Twist Clare J.,Eckroth Elena,Sposto Richard,Gaynon Paul S.,Loh Mignon L.

Funder

NIH

Leukemia & Lymphoma Society

Frank A. Campini Foundation

USC-CHLA Institute for Pediatric Clinical Research

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22612/fullpdf

Reference43 articles.

1. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials;Creutzig;Leukemia,2005

2. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials;Gibson;Leukemia,2005

3. Fifty years of studies of the biology and therapy of childhood leukemia;Kersey;Blood,1997

4. Improved treatment results for childhood acute myeloid leukemia in Taiwan;Liang;Leukemia,2006

5. Long-term results in children with AML: NOPHO-AML Study Group-Report of three consecutive trials;Lie;Leukemia,2005

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Español de Trasplante Hematopoyético);Transplantation and Cellular Therapy;2024-07

2. Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium;Cancers;2024-01-24

3. Stem Cell Transplantation and Cellular Immunotherapies for Pediatric AML;Pediatric Oncology;2024

4. Refractory/Relapsed AML in Children and Evolution of Novel Therapies;Pediatric Oncology;2024

5. Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia;Blood Research;2023-11-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3